Cargando…
Galacto-Oligosaccharides as an Anti-Infective and Anti-Microbial Agent for Macrolide-Resistant and -Sensitive Mycoplasma pneumoniae
The worldwide increase in the incidence of antibiotic resistance of the atypical bacterium Mycoplasma pneumoniae (MP) challenges the treatment of MP infections, especially in children. Therefore, alternative strategies for the treatment of MP infections are warranted. Galacto- and fructo-oligosaccha...
Autores principales: | Zhu, Hongzhen, Cai, Yang, Slimmen, Lisa J. M., de Bruijn, Adrianus C. J. M., van Rossum, Annemarie M. C., Folkerts, Gert, Braber, Saskia, Unger, Wendy W. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224470/ https://www.ncbi.nlm.nih.gov/pubmed/37242328 http://dx.doi.org/10.3390/pathogens12050659 |
Ejemplares similares
-
Galacto-oligosaccharides alleviate lung inflammation by inhibiting NLRP3 inflammasome activation in vivo and in vitro
por: Cai, Yang, et al.
Publicado: (2021) -
Dietary galacto-oligosaccharides prevent airway eosinophilia and hyperresponsiveness in a murine house dust mite-induced asthma model
por: Verheijden, Kim AT, et al.
Publicado: (2015) -
Anti-Pathogenic Functions of Non-Digestible Oligosaccharides In Vitro
por: Asadpoor, Mostafa, et al.
Publicado: (2020) -
Anti-Inflammatory Properties of Fructo-Oligosaccharides in a Calf Lung Infection Model and in Mannheimia haemolytica-Infected Airway Epithelial Cells
por: Cai, Yang, et al.
Publicado: (2021) -
Non-Digestible Oligosaccharides: A Novel Treatment for Respiratory Infections?
por: Cai, Yang, et al.
Publicado: (2022)